Validation of the SF-36 in patients with endometriosis.
Qual Life Res
; 23(1): 103-17, 2014 Feb.
Article
em En
| MEDLINE
| ID: mdl-23851974
ABSTRACT
OBJECTIVES:
Endometriosis presents with significant pain as the most common symptom. Generic health measures can allow comparisons across diseases or populations. However, the Medical Outcomes Study Short Form 36 (SF-36) has not been validated for this disease. The goal of this study was to validate the SF-36 (version 2) for endometriosis.METHODS:
Using data from two clinical trials (N = 252 and 198) of treatment for endometriosis, a full complement of psychometric analyses was performed. Additional instruments included a pain visual analog scale (VAS); a physician-completed questionnaire based on patient interview (modified Biberoglu and Behrman--B&B); clinical global impression of change (CGI-C); and patient satisfaction with treatment.RESULTS:
Bodily pain (BP) and the Physical Component Summary Score (PCS) were correlated with the pain VAS at baseline and over time and the B&B at baseline and end of study. In addition, those who had the greatest change in BP and PCS also reported the greatest change on CGI-C and patient satisfaction with treatment. Other subscales showed smaller, but significant, correlations with change in the pain VAS, CGI-C, and patient satisfaction with treatment.CONCLUSIONS:
The SF-36--particularly BP and the PCS--appears to be a valid and responsive measure for endometriosis and its treatment.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psicometria
/
Qualidade de Vida
/
Inquéritos e Questionários
/
Perfil de Impacto da Doença
/
Endometriose
Tipo de estudo:
Qualitative_research
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article